Standard
FDA Clears Biometric Tool Neurora to Assist Clinicians in Diagnosing Autism in Children
Federal regulators have granted clearance to a novel diagnostic support tool designed to assist clinicians in identifying autism spectrum disorder in children, marking another step forward in the integration of biometric technology into pediatric healthcare. The Food and Drug Administration cleared Neurora this month to inform clinical decisions regarding the diagnosis of children ranging from…
